Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-27

Clinical Trial Update: Study of DCR-AUD in Healthy Volunteers [Phase 1]

View source ↗

Summary

DCR-AUD, the investigational therapy from Dicerna (a Novo Nordisk company), completed its Phase 1 study in healthy volunteers for Alcohol Use Disorder, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DCR-AUD

Snippet

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | Conditions: Alcohol Use Disorder (AUD) | Phase 1 | Status: COMPLETED | Results posted: 2024-12-27